Drug Type CAR-T |
Synonyms- |
Target |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ImmPACT Bio USA, Inc.Startup |
Active Organization ImmPACT Bio USA, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Cancer | Preclinical | US | ImmPACT Bio USA, Inc.Startup | 28 Nov 2023 |